MAPT and early-onset autosomal dominant Alzheimer disease: Retinoic acid plays a potential role in modulating Aβ plaque aggregation, tau hyperphosphorylation, inflammation and oxidative stress, and RAR signalling pathways and neurotransmission, all of which are altered in Alzheimer’s disease and are correlated to the development and progression of the disease [3].